“…The recent discovery of a large number of tubulin-modifying enzymes now allows to directly address the role of tubulin PTMs (Janke, 2014). Cytosolic carboxypeptidases (CCPs) (Kalinina et al, 2007;Rodriguez de la Vega et al, 2007) are a class of tubulinmodifying enzymes that remove acidic amino acid residues from the carboxy-termini of peptide chains Berezniuk et al, 2012), thus controlling two major types of PTMs: First, they reverse polyglutamylation, a PTM catalyzed by polyglutamylases from the tubulin-tyrosine ligase-like (TTLL) family (Janke et al, 2005;van Dijk et al, 2007), and second, CCPs can remove C-terminal, gene-encoded glutamate residues, which converts a-tubulin into D2and D3-tubulins Aillaud et al, 2016) or affects other proteins with acidic C-termini (Tanco et al, 2015). Impaired deglutamylase activity was initially linked to neurodegeneration in a mouse model with early loss of the Purkinje cells in the cerebellum, the Purkinje cell degeneration (pcd) mouse (Mullen et al, 1976).…”